2012
DOI: 10.1038/nm0912-1445a
|View full text |Cite
|
Sign up to set email alerts
|

Erratum: Vitamin E decreases bone mass by stimulating osteoclast fusion

Abstract: In the version of this article initially published, it was incorrectly stated that the mice were fed a diet supplemented with α-tocopherol at 600 mg per kg of body weight. Instead, the food itself contained 600 mg of α-tocopherol per kg. The error has been corrected in the HTML and PDF versions of the article.Corrigendum: Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer In the version of this article initially … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 1 publication
0
2
0
Order By: Relevance
“…NFATc1 has an essential role in osteoclastogenesis. In response to activation of Ca 2+ /calcineurin signaling, NFATc1 is a key modulator, which activates transcription of a series of key osteoclast genes by translocating to the nucleus ( 21 ). NFATc1 is not only required but also sufficient for osteoclastogenesis, as its overexpression in osteoclast precursors has been shown to induce osteoclast differentiation in the absence of RANKL ( 22 ).…”
Section: Discussionmentioning
confidence: 99%
“…NFATc1 has an essential role in osteoclastogenesis. In response to activation of Ca 2+ /calcineurin signaling, NFATc1 is a key modulator, which activates transcription of a series of key osteoclast genes by translocating to the nucleus ( 21 ). NFATc1 is not only required but also sufficient for osteoclastogenesis, as its overexpression in osteoclast precursors has been shown to induce osteoclast differentiation in the absence of RANKL ( 22 ).…”
Section: Discussionmentioning
confidence: 99%
“…Regarding the in vitro effect of vitamin E on MSC proliferation, we observed a significant decline in the number of cells at all doses (from 0.75 to 12 µ M), from 120 h of treatment. Studies evaluating changes in cell proliferation induced by vitamin E treatment are contradictory: Fujita et al have investigated the action of vitamin E in mice deficient in the transfer protein of α -tocopherol in comparison with a wild type mouse model, documenting that osteoblastic differentiation and proliferation were not altered by vitamin E [ 22 ]. Additionally, Urban et al have observed that vitamin E treatment did not increase the osteoblast proliferation in vitro; however, they argue that high doses of this vitamin can generate toxic effects preventing osteoblast differentiation and proliferation [ 23 ].…”
Section: Discussionmentioning
confidence: 99%